<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="120866">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01701271</url>
  </required_header>
  <id_info>
    <org_study_id>MEXIS-HAIR LOSS-STUDY 1.2012</org_study_id>
    <nct_id>NCT01701271</nct_id>
  </id_info>
  <brief_title>Efficacy Study of a Cosmetic Lotion in the Treatment of Androgenetic Alopecia in Males and Females</brief_title>
  <acronym>MEXISPATENT</acronym>
  <official_title>Evaluation of the Efficacy of the Hair Loss Prevention Cosmetic Lotion MPAF MEXIS M6S PATENT in the Treatment of Androgenetic Alopecia by Decreasing of Hair Loss and Strengthening and Thickening of Hair in Males and Females.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mexis George</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mexis George</source>
  <oversight_info>
    <authority>Greece: National Organization of Medicines</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the Hair Loss Prevention Lotion named
      MEXIS,MPAF, M6S PATENT is effective in the treatment of Androgenetic Alopecia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study verifies whether the tested product has any efficacy in the treatment of
      Androgenetic Alopecia.

        -  The evaluated product (Hair Loss prevention Lotion) is called:MEXIS, MPAF, M6S PATENT.

        -  20 volunteers both men and women suffering from hair loss both in parties and over the
           entire scalp with age between 18 and 70 years have been selected for this test .

        -  Samples of the product have been applied following their usual use: as they are.

        -  On the selecting volunteers have been used:

             1. The pull test by pulling with fingers of some hair and counting them to estimate
                the evolution  of the pathology.

             2. A sebum-meter to check the presence of scales on the scalp.

             3. A polarized light video-camera to check the redness of the scalp and to have a
                picture of hair and scalp.

        -  Volunteers were also asked about:

        -  Fluffiness

        -  Sheen

        -  Itching

        -  Presence of scales on scalp

        -  Oily hair

        -  Product's acceptability

        -  The readings are taken at 0 time (basal value), after 15 days (t15), 30 days (t30), 45
           days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the
           medical studio. Then they analyzed and reported in a graph.

        -  Summarizing tables and graphs of the data were taken during experimentation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2001</start_date>
  <completion_date type="Actual">June 2001</completion_date>
  <primary_completion_date type="Actual">June 2001</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Decrease of hair loss in a pull test and thickening of hair on a polarized light video-camera as a measure of Efficacy</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurement of the decrease of hair loss by pull test and pulling some hair with the fingers and of the thickening of hair with the polarized light video-camera.
Measurements estimated and reported every 15 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Decrease of sebum on a sebum-meter, of dandruff, redness and oiliness on a polarized light video-camera as a measure of Efficacy</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurements checked and reported every 15 days of the decrease of existing sebum on the scalp of the volunteers with a sebum-meter and of the decrease of dandruff, redness and oiliness on the scalp of the volunteers with a polarized light video-camera.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Androgenetic Alopecia</condition>
  <arm_group>
    <arm_group_label>volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 volunteers both men and women with an age between 18 and 70 years suffering from Androgenetic Alopecia in several types apply on the scalp drops of the Hair Loss Prevention Lotion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hair loss prevention lotion</intervention_name>
    <description>For greatest problems 20 drops on the scalp per day for 3 months. For minor problems 10 drops on the scalp three times per week for 3 months.</description>
    <arm_group_label>volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good state of general health

          -  Suffering from hair loss

          -  No pharmacological treatment in progress

          -  Promise not to change the usual daily routine

          -  No atopy in the anamnesis

        Exclusion Criteria:

          -  Illness

          -  Good state of hair

          -  Pharmacological treatment in progress

          -  Denial of the continuance of the usual daily routine

          -  Atopy in the anamnesis
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fulvio Marzatico, Monitor</last_name>
    <role>Study Chair</role>
    <affiliation>Bio Basic EuropeResearch, Development and Dermo-Cosmetoligical Documentation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>George Mexis</name>
      <address>
        <city>Athens</city>
        <zip>11253</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 3, 2012</lastchanged_date>
  <firstreceived_date>October 1, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Baldness</keyword>
  <keyword>Androgenetic Alopecia</keyword>
  <keyword>Alopecia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
